Table 2. Quality-of-life outcomes after POEM procedure.
| Study | QOL assessment tools | Best score | Preoperative | Postoperative | P value | Assessment intervals (months) | Compliance | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | n | Mean | SD | n | ||||||
| Meireles et al.7) | GERD-HRQL | 50 | 20 | – | 3 | 11.3 (7 days) 2 (30 days) |
– | 3 | – | 7 days, 30 days | 3/5 (60%) |
| Ling et al.8) | SF-36 (Sum Physical) |
100 | 32.6 | 11.2 | 87 | 68.5 | 18.3 | 87 | <0.001 | The last follow-up | – |
| SF-36 (Sum Mental) |
100 | 44.1 | 12.9 | 87 | 67.4 | 14.6 | 87 | =0.003 | |||
| Orenstein et al.9) | GERD-HRQL | 50 | 18.28 | – | 40 | 5.26 | – | 40 | – | – | 40/40 (100%) |
| SF-12 (Sum Physical) |
100 | 41.98 | – | 40 | 46.48 | – | 40 | – | |||
| SF-12 (Sum Mental) |
100 | 42.54 | – | 40 | 52.02 | – | 40 | – | |||
| Li et al.10) | SF-36 (Sum Physical) |
100 | 76.25 | 37.52 | 15 | 92.25 | 12.94 | 15 | – | 1, 6 | 15/15 (100%) |
| SF-36 (Sum Mental) |
100 | 90 | 25.12 | 15 | 92.25 | 8.23 | 15 | – | |||
| Liu et al.11) | SF-36 (Sum Physical) |
100 | 71.47 | 30.08 | 35 | 93.66 | 14.96 | 35 | – | 1, 6 | 35/35 (100%) |
| SF-36 (Sum Mental) |
100 | 73.88 | 26.06 | 35 | 90.15 | 11.83 | 35 | – | |||
| Vigneswaran et al.12) | SF-36 (Sum Physical) |
100 | 74.25 | 35.43 | 37 | 88.75 | 35.37 | 19 | – | 3 weeks, 6, 12 | 19/37 (51%) |
| SF-36 (Sum Mental) |
100 | 71 | 34.72 | 37 | 79.5 | 23.40 | 19 | – | |||
| Hoppo et al.13) | GERD-HRQL | 50 | 16.3 | 11.6 | 19 | 6.7 | 8.1 | 19 | 0.003* | 6 weeks, 6, 12 | 19/25 (76%) |
| Jones et al.14) | GERD-HRQL | 50 | 22 | 9.15 | 43 | 8 | 6.89 | 42 | <0.001 | 6 | 42/43 (98%) |
| Hernández Mondragón et al.15) | AE-18 | 90 | 40 (28–53) | – | 65 | 68 | – | 50 | – | 1, 6, 12, 24, 36, 48 | 50/65 (77%) |
| Peng et al.16) | SF-36 (Sum Physical) |
100 | 76.73 | 13.62 | 13 | 81.3 | 11.83 | 13 | – | 36 | 13/13 (100%) |
| SF-36 (Sum Mental) |
100 | 68.15 | 16.88 | 13 | 72.53 | 16.88 | 13 | – | 36 | ||
| Ward et al.17) | SF-36 (Sum Physical) |
100 | 68.68 | 41 | 75.05 | 41 | – | 3 weeks, 6,12 | 25/41(60%) | ||
| SF-36 (Sum Mental) |
100 | 64 | 41 | 73.45 | 41 | – | |||||
| GERD-HRQL | 50 | 16.5 | 41 | 6.79 | 41 | <0.05 | |||||
| Perbtani et al.18) | SF-36 (Sum Physical) |
100 | 55.8 | 2.2 | 143 | 63.6 | 3.3 | 41 | <0.05 | 1, 6, 12 | 41/143 (29%) |
| SF-36 (Sum Mental) |
100 | 61.5 | 2.2 | 143 | 71.2 | 3.6 | 41 | <0.05 | |||
0.05 is considered significant.
AE-18: A disease-specific questionnaire for achalasia developed and validated in Spanish language with 18 items and four subscales; GERD-HRQL: gastroesophageal reflux disease health-related quality of life; POEM: peroral endoscopic myotomy; QOL: quality of life; SD: standard deviation; SF-36: 36-item Health Survey; SF-12: 12-item Health Survey